The push for regulation of premium cigars by the FDA becoming a reality. The White House Office of Management and Budget (OMB) and Office of Information and Regulatory Affairs (OIRA) has released their latest version of the proposed regulatory agenda. According to a communication by the International Premium Cigar and Pipe Retailers (IPCPR), this is being called “the most detailed release we have seen in recent years”.
The announcement was published and in the proposal it is stated that the proposed rule would generate some immediate quantifiable benefits by dissuading smokers of small and large cigars,” and “it would impose costs in the form of registration, submission, labeling, and other requirements.”
Last month, the push the regulatory agenda moved to the OMB to assess the economic impacts the industry. The IPCPR notes that for the first time, OIRA recognizes that proposed legislation should apply to tobacco products. In a communication by the IPCPR:
Following a year of meetings and information sharing with the Food and Drug Administration (FDA) Center for Tobacco Products (CTP), IPCPR has learned that the process to federally regulate cigars has moved into the next phase. The proposed rule on regulating cigars has moved from the Department of Health and Human Services (HHS) to the OMB for review. This agency will analyze the rule and determine its economic impact on the industry before it is released for public comment. It is critical that you are prepared for public comment period to be sure the voice of the retail tobacconist is heard.